Sagimet Biosciences

SGMT • NASDAQ • Stock Fundamentals

Sagimet Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David A. Happel, with a market cap of $445.8M.

Market Cap$445.8M

Employees10.0

CEODavid A. Happel

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Sagimet Biosciences

Sagimet Biosciences (SGMT) has a market capitalization of $445.8M and trades on NASDAQ.

Sagimet Biosciences has approximately 10 employees.